Home
  • login
  • Twitter
  • facebook
Search for Poster
Date/TimePoster TitlePoster Number
Sep 24
10:00 AM-5:00 PM
Evaluation of Radiation-Induced Cardiac Toxicity in Breast Cancer Patients Treated with Trastuzumab-Based Chemotherapy 2000
Sep 24
10:00 AM-5:00 PM
Reduced Mean Cardiac Dose: An Additional Benefit of Hypofractionated Whole Breast Radiotherapy? 2001
Sep 24
10:00 AM-5:00 PM
Comparison of Heart Dose in Early Stage Left Sided Breast Cancers Treated with IORT or EBRT-DIBH 2002
Sep 24
10:00 AM-5:00 PM
Prevalence and Impact of Variants of Uncertain Significance on Local Therapy Decision-Making in Newly Diagnosed Breast Cancer Patients 2003
Sep 24
10:00 AM-5:00 PM
In Vivo Dosimetry for Single Fraction Intraoperative Electron Radiation Therapy for Early Stage Breast Cancer 2004
Sep 24
10:00 AM-5:00 PM
Acute Skin Toxicity is Comparable Between Brass Bolus and 0.5 Mm Tissue Equivalent Bolus Among Women Receiving Postmastectomy Irradiation Using Mixed Energy Photons 2005
Sep 24
10:00 AM-5:00 PM
Early Results of Toxicity for High-Risk Patients Treated With Hypofractionated Regional Nodal Irradiation. 2006
Sep 24
10:00 AM-5:00 PM
Exploring the Usefulness of Concurrent Chemoradiation for Bulky Disease in the Setting of Advanced/Inoperable or Metastatic Breast Cancer 2007
Sep 24
10:00 AM-5:00 PM
Is Pathological Complete Response Rate Associated with Improved Local Control in Localized Triple Negative Breast Cancer After Neoadjuvant Chemotherapy? 2008
Sep 24
10:00 AM-5:00 PM
Hypofractionated Radiation Therapy After Extreme Oncoplasty for Patients With T2-T3 Breast Cancers: Physician Rated Cosmesis and Patient Reported Outcomes 2009
Sep 24
10:00 AM-5:00 PM
V5 Does Not Predict Pulmonary Toxicity of Intensity Modulated Radiation Therapy for Adjuvant Whole-Breast/Chest-Wall and Regional Nodal Irradiation 2010
Sep 24
10:00 AM-5:00 PM
Prospective Study of Adjuvant Accelerated Partial Breast Irradiation Using 40 Gy Daily Fractionation Following Lumpectomy 2011
Sep 24
10:00 AM-5:00 PM
Long-Term Quality of Life Outcomes of Proton Beam PBI Compared With Photon Whole Breast Radiation Therapy 2012
Sep 24
10:00 AM-5:00 PM
MiR-215 as a Biomarker of Radiation-Induced Cardiac Toxicity 2013
Sep 24
10:00 AM-5:00 PM
Comparative Analysis of Brachytherapy Versus 3D Conformal External Beam Radiation Therapy in Delivery of Accelerated Partial Breast Irradiation from a Single Institution: Determination of Clinical Effectiveness 2015
Sep 24
10:00 AM-5:00 PM
Prognosic Stage Groups Established by AJCC Staging System 8th Edition Does Not Significantly Improve Discrimination Over Classic TNM Staging in Early Stage Breast Cancer Treated With Breast Conservative Therapy 2016
Sep 24
10:00 AM-5:00 PM
Lack of Consensus Guideline Driven Approach for Utilization of Accelerated Partial Breast Irradiation in the ASTRO “Cautionary” Group: A National Cancer Database Analysis 2017
Sep 24
10:00 AM-5:00 PM
Utility of Preoperative Breast MRI in Patient Selection for Accelerated Partial Breast Irradiation by Different Consensus Guidelines 2018
Sep 24
10:00 AM-5:00 PM
Evaluation of Partial Breast Reirradiation with IORT for Locally Recurrent Breast Cancer: A Single-Institution Report of Outcomes and Toxicity 2019
Sep 24
10:00 AM-5:00 PM
Pathologic Response and Acute Toxicity:  Planned Interim Analysis of the Phase 2 NeoRT Trial Evaluating Preoperative Single Fraction Partial Breast Radiation Therapy in Early Stage Breast Cancer 2020
Sep 24
10:00 AM-5:00 PM
Breast Sarcomas and Malignant Phyllodes: A 10-Year Retrospective Study 2021
Sep 24
10:00 AM-5:00 PM
Failure Patterns of Luminal B Breast Cancer Following Postoperative Adjuvant Radiation Therapy 2022
Sep 24
10:00 AM-5:00 PM
Locoregional Treatment of the Primary Tumor Shows Survival Benefit in De Novo Stage IV Breast Cancer 2023
Sep 24
10:00 AM-5:00 PM
Outcomes of Curative-Intent Treatment for Breast Cancer Patients Presenting with Sternal or Mediastinal Involvement 2024
Sep 24
10:00 AM-5:00 PM
Obesity and Survival in women with Invasive Breast Cancer Receiving Neoadjuvant Chemotherapy: Role of Tumor Subtype and Race 2025
Sep 24
10:00 AM-5:00 PM
Cosmetic Outcomes and Toxicity in Patients Treated With Proton Therapy After Breast Conserving Surgery 2026
Sep 24
10:00 AM-5:00 PM
Impact of Chemotherapy on Acute Toxicity in Breast Cancer Patients Treated with Breast Conserving Surgery and Hypofractionated Whole Breast Irradiation: A Single Institution Experience 2027
Sep 24
10:00 AM-5:00 PM
Impact of Collagen Vascular Disease on Radiation-Related Toxicity in Breast Cancer Patients: A Matched Pair Analysis 2028
Sep 24
10:00 AM-5:00 PM
Systemic Muscle Loss As a Consequence of Breast Radiotherapy 2029
Sep 24
10:00 AM-5:00 PM
Patterns of Locoregional Recurrence in Breast Cancer Patients After Neoadjuvant Chemotherapy and Adjuvant Radiation Therapy 2030
Sep 24
10:00 AM-5:00 PM
Incidence of PET/CT Detected Internal Mammary Nodal Involvement in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy 2031
Sep 24
10:00 AM-5:00 PM
Molecular Subtypes and Pathogenic Germline Mutations Vary by Ethnicity in Young Women Treated With Breast-Conserving Surgery and Radiation Therapy 2032
Sep 24
10:00 AM-5:00 PM
The Initial Clinical Experience of a Novel Breast Specific Stereotactic Radiosurgery Device 2033
Sep 24
10:00 AM-5:00 PM
Toxicity Profiles Following Whole Breast Irradiation plus Sequential Boost using Hypofractionated or Conventionally Fractionated Treatment 2034
Sep 24
10:00 AM-5:00 PM
A Simplified Risk Score to Predict Brain Metastasis in Triple Negative Breast Cancer Receiving Neoadjuvant Chemotherapy and Adjuvant Radiation Therapy 2035
Sep 24
10:00 AM-5:00 PM
An Analysis of the Utilization of Hypofractionated Regimens for Early Stage Breast Cancer at a Tertiary Care Cancer Center and Its Community-Based Affiliates 2036
Sep 24
10:00 AM-5:00 PM
Influence of Molecular Subtype on Tumor Response for Breast Cancer Brain Metastases Treated With Stereotactic Radiosurgery 2037
Sep 24
10:00 AM-5:00 PM
Adoption of Hypofractionated Radiation Therapy for Early Stage Breast Cancer in a Community Based Radiation Oncology Practice 2038
Sep 24
10:00 AM-5:00 PM
Intensity Modulated Proton Therapy for Accelerated Partial Breast Irradiation: A Single Institution Experience 2039
Sep 24
10:00 AM-5:00 PM
Factors Associated With MRI Screening in Women With a Personal History of Invasive, Unilateral Breast Cancer Predominately Encompass Detectability Concerns Rather Than Future Breast Cancer Risk 2040
Sep 24
10:00 AM-5:00 PM
5 Fraction Accelerated Partial Breast Irradiation Using Non-invasive Image-Guided Breast Brachytherap: Feasibility and Acute Toxicity 2041
Sep 24
10:00 AM-5:00 PM
A Pilot Study of Cardiac13N-Ammonia PET Imaging to Assess Early Cardiotoxicity Following Multibeam Intensity-Modulated Radiation Therapy for Breast Cancer 2042
Sep 24
10:00 AM-5:00 PM
A Nomogram for Predicting Survival in Patients With Breast Cancer Brain Metastasis 2043
Sep 24
10:00 AM-5:00 PM
Risk Factors for Implant-Based Reconstruction Failure after Mastectomy with or without Radiation in Patients Treated for Breast Cancer 2044
Sep 24
10:00 AM-5:00 PM
Catheter-Based Accelerated Partial Breast Brachytherapy Results in Excellent Patient-Reported Quality of Life 2045
Sep 24
10:00 AM-5:00 PM
Detection of Setup Errors With Body Surface Laser Scanning for Whole Breast Irradiation After Conservative Surgery 2046
Sep 24
10:00 AM-5:00 PM
Patterns of Care and Outcomes of Patients With Breast Cancer Who Refuse Recommended Therapy 2048
Sep 24
10:00 AM-5:00 PM
Second Conservative Treatment for Breast Cancer Local Recurrence Using HDR Interstitial Brachytherapy: Cosmetic Outcome and Quality of Life 2049
Sep 24
10:00 AM-5:00 PM
4-Year Experience and Future Plan of Carbon-Ion Radiation Therapy for Breast Cancer 2050
Sep 24
10:00 AM-5:00 PM
Cosmetic Outcome and Late Breast Toxicity After Intraoperative Radiation Therapy as a Single Modality or as a Boost Using the Intrabeam® Device: A Prospective Study 2051
Sep 24
10:00 AM-5:00 PM
Effects of Preparatory Coaching and Practice for Deep Inspiratory Breath Hold on Cardiac Dose for Left Breast Radiation Therapy 2052
Sep 24
10:00 AM-5:00 PM
Patterns of Care and Survival Outcomes for Patients With T1-2N1 Breast Cancer Treated With Mastectomy Over 2 Decades in Korea: A Multi-institutional Study of the Korean Radiation Oncology Group 2053
Sep 24
10:00 AM-5:00 PM
Risk Factors for Regional Recurrence in Node-Negative Breast Cancer: Implications of Regional Nodal Irradiation 2054
Sep 24
10:00 AM-5:00 PM
Results of Ultrasonography-Guided Fine Needle Aspiration of Internal Mammary Lymph Node for Breast Cancer Patients Who Received Neoadjuvant Chemotherapy 2055
Sep 24
10:00 AM-5:00 PM
Normal Tissue Complication Probability Modeling of Long-Term Aesthetic Outcome After Breast-Conserving Therapy 2056
Sep 24
10:00 AM-5:00 PM
Twice-Daily Radiation Therapy for Recurrent or Resistant Breast Cancer 2057
Sep 24
10:00 AM-5:00 PM
Long-Term Outcomes of Breast Conservation Therapy in Unifocal versus Multifocal Early Stage Breast Cancer Patients 2058
Sep 24
10:00 AM-5:00 PM
Breast Cancer Survival is Improved When DCIS Accompanies Invasive Ductal Carcinoma 2059
Sep 24
10:00 AM-5:00 PM
Positron Emission Tomography/Computed Tomography (PET/CT) in the Initial Evaluation of Women with Nonmetastatic Breast Cancer Can Frequently Alter Management 2060
Sep 24
10:00 AM-5:00 PM
Young Women Who Achieve Pathologic Complete Response in the Axillary Lymph Nodes Do Not Have Improved Survival Compared to Those Who Remain Lymph Node Positive after Neoadjuvant Chemotherapy 2061
Sep 24
10:00 AM-5:00 PM
Intraoperative Radiation Therapy Versus Hypofractionated Whole Breast Irradiation in T1N0, ER Positive Patients 2062
Sep 24
10:00 AM-5:00 PM
Biological Effective Dose of Two Accelerated Partial Breast Irradiation Techniques Used in RTOG 0413/NSABP B-39 2063
Sep 24
10:00 AM-5:00 PM
Impact of Microinvasion as a Predictor of Local Recurrence in Ductal Carcinoma In Situ Treated With Breast Conserving Therapy 2064
Sep 24
10:00 AM-5:00 PM
Radiation Induced Lymphocyte Apoptosis Assay and Predictive Breast Fibrosis Nomogram: First Implementation in Daily Practice in France 2065
Sep 24
10:00 AM-5:00 PM
Are We Missing the Postoperative Cavity in Whole Breast Radiation Therapy? 2066
Sep 24
10:00 AM-5:00 PM
Radiotherapy with and without Concurrent Cisplatin for Unresectable or Inoperable Locally Advanced Triple Negative Breast Cancer 2067
Sep 24
10:00 AM-5:00 PM
The Importance of Treatment and Timing in Metaplastic Breast Cancer 2068
Sep 24
10:00 AM-5:00 PM
Risk-Adapted Postmastectomy Radiation Therapy for pT1-2N1M0 Breast Cancer: A Single Institution Study 2069
Sep 24
10:00 AM-5:00 PM
Brain Metastases in Patients with Breast Cancer Versus Non–small Cell Lung Cancer: Comparison of an Unscreened Versus a Screened Population 2070
Sep 24
10:00 AM-5:00 PM
Postmastectomy Radiation Therapy Does Not Improve Outcome for Pathologic T3N0 Breast Cancers 2071
Sep 24
10:00 AM-5:00 PM
Accelerated Hypofractionated Whole-Breast Irradiation With Concomitant Daily Boost Using Intensity-Modulated Radiation Therapy in Early Breast Cancer 2072
Sep 24
10:00 AM-5:00 PM
Whole Brain Radiation Therapy Improves Overall and Intracranial Progression-Free Survivals in Breast Cancer Patients With Brain Metastases in the Setting of Systemic Treatments 2073
Sep 24
10:00 AM-5:00 PM
A Six-year Experience of Using Moderate Deep Inspiration Breath-Hold for Patients With Early-Stage Breast Cancer and Dosimetric Comparison 2074
Sep 24
10:00 AM-5:00 PM
Acute and Chronic Toxicities from Multilumen Versus Single Lumen Brachytherapy: Correlating Clinical Outcome With Dosimetry 2075
Sep 24
10:00 AM-5:00 PM
Quantification of Cardiac Subvolume Dosimetry in Breast Cancer Patients Receiving Tangential Beam Radiation Therapy 2076
Sep 24
10:00 AM-5:00 PM
Ductal Carcinoma In Situ Has Comparable Prognosis but Different Risk Factors With Ductal Carcinoma In Situ With Micro Invasion 2077
Sep 24
10:00 AM-5:00 PM
The Role of Postmastectomy Radiation Therapy for Clinical Stage II-III Breast Cancer Patients With Pathological Complete Remission of Axillary Lymph Nodes After Neoadjuvant Chemotherapy 2078
Sep 24
10:00 AM-5:00 PM
Outcome and Late Toxicity of Breast Cancer Patients Treated with Post-Mastectomy Proton Therapy 2079
Sep 24
10:00 AM-5:00 PM
Ultrasmall Theranostic Nanoparticles for the Treatment of Multiple Brain Metastases By  Radiation Therapy: A First in Man 2080
Sep 24
10:00 AM-5:00 PM
Locoregional Management of Clinically Node-Negative Male Breast Cancer: An Analysis of a Clinical Oncology Database. 2081
Sep 24
10:00 AM-5:00 PM
Postmastectomy Chest Wall Reirradiation With Proton Therapy for Breast Cancer 2082
Sep 24
10:00 AM-5:00 PM
Rates of Whole Breast Radiation Therapy Following Intraoperative Radiation Therapy Using 2009 and 2016 ASTRO Consensus Guidelines 2083
Sep 24
10:00 AM-5:00 PM
Long-Term Outcomes of Postmastectomy Radiation Therapy: A 30-Year Experience 2084
Sep 24
10:00 AM-5:00 PM
Trends of Radiation Therapy in Metaplastic Breast Cancer—A National Cancer Database Study 2085
Sep 24
10:00 AM-5:00 PM
Early Stage Breast Cancer Patients Treated at an Academic Facility are More Likely to Receive Hypofractionation: A National Cancer Database Analysis 2086
Sep 24
10:00 AM-5:00 PM
Assessment of Radiation Trends in a Prospective Registry of Node Positive Patients With Triple Negative Breast Cancer 2087
Sep 24
10:00 AM-5:00 PM
Predictors of Outcome and Patterns of Failure for High Risk Triple Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy, Surgery and Radiation 2088
Sep 24
10:00 AM-5:00 PM
Radiation Risk Versus Projected Clinical Benefit of Surveillance Imaging for Early Detection and Treatment of Breast Cancer Metastases 2089
Sep 24
10:00 AM-5:00 PM
Multiparametric Breast MRI Analysis Predicts Axillary Nodal Involvement in Early Stage Breast Cancer 2090
Sep 24
10:00 AM-5:00 PM
Trends of Radiation Therapy in Adenoid Cystic Carcinoma of the Breast—A National Cancer Database Study 2091
Sep 24
10:00 AM-5:00 PM
Prescribing Practices of Endocrine Therapy for Ductal Carcinoma In Situ in British Columbia 2092
Sep 24
10:00 AM-5:00 PM
Dose to Upper Quadrant Musculature from Whole Breast Radiation Therapy in the Supine and Prone Positions 2093
Sep 24
10:00 AM-5:00 PM
Low Rates of Post-mastectomy Radiation in Patients With Persistent Node Positive Breast Cancer after Neoadjuvant Chemotherapy: Analysis of the National Cancer Database 2094
Sep 24
10:00 AM-5:00 PM
A Novel Delivery of Accelerated Partial Breast Irradiation Using Intraoperative Brachytherapy Device Placement and Completion of Breast Conservation Therapy Within 10 Days 2095
Sep 24
10:00 AM-5:00 PM
Risk Factors for the Development of Acute Radiation Dermatitis in Breast Cancer Patients 2096
Sep 24
10:00 AM-5:00 PM
Predictors of Breast Pain in Breast Cancer Patents One Year After Whole Breast Radiation Therapy 2097
Sep 24
10:00 AM-5:00 PM
Radiotherapy Utilization for Women over 60 with Early Stage Breast Cancer 2098
Sep 24
10:00 AM-5:00 PM
Single Institution Analysis of In-Breast Tumor Recurrence Risk after No Radiation Versus Accelerated Partial Breast Irradiation for Ductal Carcinoma in Situ 2099
Sep 24
10:00 AM-5:00 PM
Quantifying the Incidence of Homologous Recombination Repair Status in Metastatic Triple Negative Breast Cancer Receiving Concurrent Cisplatin and Radiation Therapy 2100
Sep 24
10:00 AM-5:00 PM
Efficacy of Hypofractionated Whole Breast Radiation in Women Not Meeting ASTRO Guideline Consensus: Age Younger Than 50, Grade 3 Disease, or Prior Chemotherapy 2101
Sep 24
10:00 AM-5:00 PM
Outcomes of Intraoperative Radiotherapy for Breast Cancer: Experience from a Multidisciplinary Breast Oncology Program at an NCI Designated Cancer Center 2102
Sep 24
10:00 AM-5:00 PM
Trends in Utilization of Hypofractionated Whole Breast Irradiation in Triple Negative Breast Cancer: A National Cancer Database Analysis 2103
Sep 24
10:00 AM-5:00 PM
The Role of Postmastectomy Radiation Therapy in Clinical T1-3N1M0 Breast Cancer Patients With Pathological Negative Lymph Nodes After Neoadjuvant Chemotherapy and Mastectomy 2104
Sep 24
10:00 AM-5:00 PM
The Role of Postmastectomy Radiation Therapy in Locally Advanced Breast Cancer Patients Treated With Neoadjuvant Chemotherapy and Mastectomy 2105
Sep 24
10:00 AM-5:00 PM
Long-Term Cosmesis Following a Novel Schedule of Accelerated Partial Breast Radiation in Selected Early Stage Breast Cancer: Result of a Prospective Clinical Trial 2106
Sep 24
10:00 AM-5:00 PM
Mean Heart Dose and Distribution of Coronary Artery Stenosis in Breast Cancer Patients Treated With CT-Based Radiation Therapy 2107
Sep 24
10:00 AM-5:00 PM
Obesity Drives Prognosis in Women with Metastatic Breast Cancer 2108
Sep 24
10:00 AM-5:00 PM
Effect of Age in Young Women With Stage I-III Triple-Negative Breast Cancer: A Report From the National Cancer Database 2109
Sep 24
10:00 AM-5:00 PM
Regional Nodal Irradiation in Breast Cancer: A Patterns of Care Survey of Radiation Oncologists 2110
Sep 24
10:00 AM-5:00 PM
Impact of Regional Nodal Irradiation After Neoadjuvant Chemotherapy in Breast Cancer Patients With Cytologically Confirmed Axillary Lymph Node Metastases 2111
Sep 24
10:00 AM-5:00 PM
Patterns of Fractionation and Boost Utilization in Adjuvant External Beam Radiation Therapy for Ductal Carcinoma In Situ in the United States 2112
Sep 24
10:00 AM-5:00 PM
Radiotherapy May Play an Important Role in Improving the Efficacy of Breast-Conserving Therapy Compared with Mastectomy in Patients with T1-2N1M0 Breast Cancer 2113
Sep 24
10:00 AM-5:00 PM
Three-Year Outcome Evaluation of Deep Inspiration Breath Hold Technique in Post–Radiation Therapy Patients After Left-Sided Breast-Conserving Surgery by Echocardiography With Quantitative Tissue Velocity Imaging 2114
Sep 24
10:00 AM-5:00 PM
Predictors of Pathological Complete Response and Outcome in HER2 Positive Breast Cancer Patients Treated With Neoadjuvant Systemic Therapy, Surgery, and Radiation Therapy 2115
Sep 24
10:00 AM-5:00 PM
Electronic Brachytherapy at the Time of Breast Conservation Surgery for Early-Stage Breast Cancer: Early Follow-Up Results of a Nonrandomized, Multicenter Trial 2116
Sep 24
10:00 AM-5:00 PM
Cardiac Motion Tracked on Cine MRI in Free-Breathing and Deep Inspiration Breath Hold:  Effect on Dose Delivered to the Heart in Breast Cancer Patients 2117
Sep 24
10:00 AM-5:00 PM
Dosimetric Comparison Between 2D and 3D Treatment Planning in Breast Cancer When Using the RTOG Breast Contouring Atlas 2118
Sep 24
10:00 AM-5:00 PM
Prognostic Value of HER2 Status in Breast Cancer Patients With Brain Metastases 2119
Sep 24
10:00 AM-5:00 PM
Effect of Margin Status on 10-Year Local Recurrence and Survival Outcomes in a Large Population-Based Analysis of Women Treated With Breast-Conserving Therapy 2120
Sep 24
10:00 AM-5:00 PM
Radiation Therapy Planning Using Bioeffect Modeling for Left-Sided Breast Cancer 2121
Sep 24
10:00 AM-5:00 PM
Prone Positioning in the Treatment of the Whole Breast and Regional Lymphatics Using a Mono-Isocentric Four Field Radiation Technique: A Dosimetric Comparison 2122
Sep 24
10:00 AM-5:00 PM
Long-Term Radiographic Findings After Baloon Based Accelerated Partial Breast Irradiation 2123
Sep 24
10:00 AM-5:00 PM
Predicting Recurrence in Triple Negative Breast Cancer Patients from Clinical Parameters Using a Multi-Objective Classifier 2124
Sep 24
10:00 AM-5:00 PM
Prognosic Stage Groups Established by AJCC Staging System 8th Edition May Help to Individualize Postmastectomy Radiation Therapy in T1-2N1M0 Breast Cancer 2125
Sep 24
10:00 AM-5:00 PM
Assessing Outcomes in the Management of Postmastectomy Local-Regional Recurrences in Breast Cancer 2126
Sep 24
10:00 AM-5:00 PM
Temporal and Spatial Quantification of Tissue Oxygen Saturation and Melanin Deposition During Whole Breast Radiation Using Noninvasive Spatial Frequency Domain Imaging 2127
Sep 24
10:00 AM-5:00 PM
Three Year Local Control, Overall Survival, and Toxicity From a Prospective Phase 2 Study of Intraoperative Radiation Therapy  in Elderly Patients with Small Breast Cancer (TARGIT E) 2128
Sep 24
10:00 AM-5:00 PM
Long-Term Cosmetic Outcome after Hypofractionated, Normofractionated, and Intraoperative Breast Radiation Therapy: A Photographic Evaluation Study 2129
Sep 24
10:00 AM-5:00 PM
Long-Term Outcomes for Validation of Cardiac-Sparing Breast Cancer Treatment Techniques 2130
Sep 24
10:00 AM-5:00 PM
Toxicity Outcomes for Immediate and Delayed Autologous Reconstruction in Patients Receiving Post-mastectomy Radiation Therapy: Is It Time to Reconsider Sequencing? 2131
Sep 24
10:00 AM-5:00 PM
The Impact of Adjuvant Radiation Timing on Survival After Breast Conserving Surgery in Early Stage Breast Cancer Patients 2132
Sep 24
10:00 AM-5:00 PM
Postmastectomy Radiation Therapy in Breast Cancer Patients With Nodal Micrometastases 2133
Sep 24
10:00 AM-5:00 PM
Patterns of Locoregional Failure in Women With Early Stage Breast Cancer Treated by Whole Breast Radiation Therapy in the Lateral Isocentric Decubitus Position: Large-Scale Single Center Experience 2134
Sep 24
10:00 AM-5:00 PM
Characteristics of Radiation Therapy for Medullary Carcinoma of the Breast in the National Cancer Database 2135
Sep 24
10:00 AM-5:00 PM
HEART (Heart Evaluation After Radiatiom Therapy): Novel Detection of Cardiotoxicity in Breast Cancer Patients 2136
Sep 24
10:00 AM-5:00 PM
Does Breast Conserving Therapy  and Mastectomy Yield Similar Outcomes Following Neoadjuvant Chemotherapy With Pathological Complete Response? 2137
Sep 24
10:00 AM-5:00 PM
The Influence of Histologic Grade on Outcomes of Elderly Women with Early Stage Breast Cancer Treated With Breast Conserving Surgery With or Without Radiation Therapy 2138
Sep 24
10:00 AM-5:00 PM
Additional Surgeries After Breast Reconstruction in Patients With Breast Cancer Undergoing Mastectomy 2139
Sep 24
10:00 AM-5:00 PM
Radiosensitivity Effect and Regulatory Mechanisms of PARP-1 Inhibitors on Brca Mutant Breast Cancer 2140
Sep 24
10:00 AM-5:00 PM
Acute and Late Toxicity of Uniform Scanning Proton Therapy for Breast Cancer Patients 2141
Sep 24
10:00 AM-5:00 PM
Prognostic Factors and Local Recurrence Pattern in Breast Phyllodes Tumors: A Nomogram Based on Retrospective Cohort Study of 404 Cases 2142
Sep 24
10:00 AM-5:00 PM
Evaluation of Single Fraction High-Gradient Partial Breast Irradiation as the Sole Method of Radiation Therapy for Low-Risk Stage 0 and I Breast Cancer—Early Results of a Single Institution Prospective Clinical Trial 2143